Viewing Study NCT01817751


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT01817751
Status: COMPLETED
Last Update Posted: 2024-07-17
First Post: 2013-03-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Sponsor: Virginia Commonwealth University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MCC-14816
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View